NYSE$VTR

Ventas Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Ventas's fourth quarter results exceeded expectations, driven by strong performance in senior housing and office segments, and strategic investments.

Ventas reported fourth-quarter results ahead of expectations, driven by execution amid COVID-19 waves. The company positioned itself to capture upside in senior housing recovery, delivered organic growth in Office and healthcare triple-net, and invested $3.7 billion in senior housing and life science.

  • Total SHOP portfolio NOI achieved the high end of expectations in Q4 2021.
  • Same-store average occupancy grew by 200 basis points to 83.4% in Q4 2021 versus Q4 2020.
  • Medical Office Building (MOB) same-store cash NOI grew 3.4% year-over-year.
  • Ventas completed or announced $3.7 billion in strategic investments in 2021.

Headline financials

Total Revenue

$1.02B

Previous: $921M+10.9%
EPS (adj)

$0.73

Previous: $0.83-12.0%
Net Income

-$39.1M

Previous: $112M-134.9%
Operating Income

-$66.3M

Previous: $71.5M-192.7%
Gross Profit

$440M

Previous: $458M-3.9%
Cash & Equivalents

$150M

Previous: $413M-63.8%
Total Assets

$24.7B

Previous: $23.9B+3.3%
Stock-Based Comp

$5.8M

Previous: $4.17M+39.3%

Revenue & EPS history

Ventas · Revenue · Quarterly

$1.02B

Q4 2021+10.9%vs Q4 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

Ventas · $670M total across 3 segments · Q4 2021

  • Resident fees and services
    $647M+22.2%
  • Interest and other income
    $13.5M+1991.0%
  • Income from loans and investments
    $9.58M-47.7%

Forward guidance

The Company currently expects to report first quarter 2022 Net Income (Loss) Attributable to Common Stockholders, Nareit FFO and Normalized FFO per share and same-store Cash NOI growth within the following ranges, which include $33 million (or $0.08 per share) of net HHS Grants received to date in the first quarter 2022

Tailwinds

  • Ventas expects first quarter 2022 year-over-year same-store SHOP revenue to increase approximately 10% versus first quarter 2021.
  • SHOP NOI is expected to grow in the range of 6% to 15% in the first quarter 2022, excluding net HHS Grants in all periods, with the range principally a function of operating expense assumptions.
  • Average occupancy for the first quarter 2022 in the same-store year-over-year SHOP business of 321 assets is expected to increase approximately 410 basis points at the midpoint of the Company’s expectations versus first quarter 2021.
  • Revenue for the same-store SHOP business is expected to grow 10% at the midpoint of the Company’s expectations in the first quarter 2022 as compared to the first quarter 2021 principally through strong in-place rate increases implemented in the first quarter 2022 and improving re-leasing spreads.
  • The Office business year-over-year same-store cash NOI is expected to increase approximately 4.5% at the midpoint of the Company’s expectations versus first quarter 2021 due to occupancy growth in MOB and strong expense controls.

Headwinds

  • A tight labor market, and increased staff absences due to COVID-19 protocols, have driven elevated labor and agency costs in the first quarter 2022 to date.
  • At the guidance midpoint, Ventas expects operating costs to remain elevated through the first quarter even as COVID-19 clinical conditions moderate.
  • The Company’s guidance assumes that no additional HHS Grants are received during the quarter.
  • The guidance does not assume any new or unannounced material acquisitions or capital markets activities.
  • The trajectory and future impact of the COVID-19 pandemic, including the impact of any variant, on various aspects of our business, remain highly uncertain and may change rapidly.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.6%

Avg return

Earnings day

+1.1%

Avg return

5 days after

+2.3%

Avg return

30 days after

58%

42 / 73 earnings

Positive

+13.9%

Q3 2020

Best reaction

-10.8%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+3.9%+1.7%
Q4 2025+3.4%+7.3%+6.3%
Q3 2025+6.8%+7.4%+15.5%
Q2 2025+0.5%+2.0%+1.3%
Q1 2025-6.5%-6.1%-8.3%
Q4 2024+8.3%+11.4%+11.6%
Q3 2024-0.8%-2.5%-3.0%
Q2 2024+3.6%+5.0%+14.1%
Q1 2024+4.4%+6.3%+13.5%
Q4 2023-0.6%-1.6%-4.5%
Q3 2023+3.0%+2.3%+9.3%
Q2 2023-7.3%-6.2%-11.1%
Q1 2023-2.1%-2.8%-3.1%
Q4 2022-1.7%-2.0%-13.9%
Q3 2022+5.7%+13.0%+23.7%
Q2 2022-5.1%-1.9%-8.2%
Q1 2022-1.4%-8.9%-2.7%
Q4 2021+1.0%+0.9%+13.4%
Q3 2021-0.5%+3.7%-10.7%
Q2 2021-4.3%-5.1%-6.1%
Q1 2021+1.7%-3.4%+5.1%
Q4 2020+3.5%+7.9%+7.6%
Q3 2020+13.9%+17.8%+20.3%
Q2 2020+7.8%+4.0%+12.8%
Q1 2020+7.2%-1.1%+59.8%
Q4 2019+6.5%+1.1%-63.4%
Q3 2019-10.8%-10.4%-20.8%
Q2 2019+0.1%-0.3%+6.7%
Q1 2019+0.7%+2.8%+10.9%
Q4 2018-1.1%-0.4%-3.8%
Q3 2018+0.6%+2.0%+8.0%
Q2 2018-3.3%-0.9%+2.4%
Q1 2018+8.3%+10.3%+13.0%
Q4 2017-0.9%-2.6%-2.4%
Q3 2017+3.5%+3.2%+5.9%
Q2 2017-0.1%-2.1%+0.7%
Q1 2017-0.2%-2.1%+3.8%
Q4 2016+1.6%-0.2%-2.1%
Q3 2016+2.0%-4.8%-9.3%
Q2 2016+2.7%-1.1%-3.2%
Q1 2016+0.6%
Q4 2015+2.1%
Q3 2015-5.7%
Q2 2015+3.8%
Q1 2015-1.0%
Q4 2014-0.7%
Q3 2014-0.6%
Q2 2014-0.3%
Q1 2014+2.2%
Q4 2013-1.9%
Q3 2013+0.9%
Q2 2013-1.1%
Q1 2013+0.5%
Q4 2012+2.3%
Q3 2012+0.4%
Q2 2012+2.2%
Q1 2012+0.1%
Q4 2011+1.1%
Q3 2011+0.9%
Q2 2011-9.3%
Q1 2011-1.7%
Q4 2010-6.2%
Q3 2010-0.5%
Q2 2010+4.0%
Q1 2009-0.8%
Q1 2010-1.6%
Q4 2007+0.2%
Q4 2009+0.2%
Q3 2008-2.1%
Q3 2009-2.1%
Q2 2008+1.7%
Q2 2009+1.7%
Q4 2008+1.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro